There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
| Orders | Qty | Bid |
|---|---|---|
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| Ask | Qty | Orders |
|---|---|---|
| 582.5 | 1 | 1 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
| 0 | 0 | 0 |
Annual Revenue,rose 20.49%, in the last year to ₹846.03 Cr. Its sector's average revenue growth for the last fiscal year was 20.05%.Annual Net Profit,rose 78.17% in the last year to ₹163.04 Cr. Its sector's average net profit growth for the last fiscal year was -20.19%.Price to Earning Ratio,is 54.91, lower than its sector PE ratio of 58.98.
Thyrocare Technologies Limited is a listed diagnostics company headquartered in Navi Mumbai, delivering IT-enabled, fully automated laboratory services since 1996 and incorporated on January 28, 2000. It operates a nationwide network of 29 NABL-accredited laboratories comprising 2 Central Processing Labs, 19 Regional Processing Labs, 2 Zonal Processing Labs and 6 Satellite Processing Labs, with a growing international footprint that includes a laboratory in Tanzania. Its consumer and clinician-focused portfolios span Aarogyam (preventive health), Jaanch (doctor-curated diagnostics) and Her Check (women’s wellness). The company reports industry-leading turnaround, releasing 98% of reports within six hours. Equity shares are listed on NSE and BSE. Thyrocare offers over 920 diagnostic tests delivered to homes across 4,600 pin codes and provides ECG at Home services in 1,000+ pin codes. The company has 3 subsidiaries. Key milestones in the latest year include strategic acquisitions, expansion of accredited labs and commissioning of the Tanzania lab.
Products and services include diagnostic testing services, imaging services and sale of testing equipment and consumables (including glucometers and glucostrips under the Sugarscan brand).
The intraday low for Thyrocare Technologies Ltd on the NSE today was ₹577.00. The stock's 52-week low stands at ₹342.55, recorded on 23 Mar 2026. Today's low is 68.44% above the 52-week low, indicating the stock is trading well above its yearly lows.
As of 19 Aug 2026, the share price of Thyrocare Technologies Ltd is ₹580.00 on the NSE and ₹582.80 on the BSE. The stock opened at ₹620.00, touched a high of ₹630.00 and a low of ₹577.00 during today's session.
Over the last 6 months, Thyrocare Technologies Ltd has given a return of 49.19%. The stock was priced at ₹407.70 on 19 Feb 2026 and has Rise to ₹580.00 as of 19 Aug 2026, a change of ₹172.30 per share.
Thyrocare Technologies Ltd has delivered 31.67% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹662.00 on 12 Aug 2026 and a 52-week low of ₹342.55 on 23 Mar 2026. It is currently trading at ₹580.00 as of 19 Aug 2026.
The all-time high (ATH) for Thyrocare Technologies Ltd was ₹649.35, recorded on 11 Aug 2026. At the current price of ₹580.00, the stock is trading 10.68% below its all-time high. The all-time low recorded was ₹138.43 on 30 Jul 2019.
Thyrocare Technologies Ltd has delivered a return of 29.24% over the last 3 months. The stock was trading at ₹470.65 on 19 May 2026 and is currently at ₹580.00 as of 19 Aug 2026, reflecting a Gain of ₹109.35 per share over this period.
Thyrocare Technologies Ltd has delivered a 41.65% absolute return over the past 5 years, equivalent to a CAGR of 7.21% per annum. The stock was priced at ₹409.46 in Aug 2021 and has risen to ₹580.00 as of 19 Aug 2026. An investment of ₹1,00,000 in Thyrocare Technologies Ltd five years ago would be worth ₹1,41,650.00 today.
Yes,Thyrocare Technologies Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 86.00 per share between FY2022 and FY2026, with the most recent dividend of ₹7.00 per share for May 26, with an ex-dividend date of 23 Jun 2026. At the current market price of ₹580.00, the trailing dividend yield of Thyrocare Technologies Ltd stands at 35.00%.
The intraday high for Thyrocare Technologies Ltd on the NSE today (19 Aug 2026) was ₹630.00. This compares to the 52-week high of ₹662.00 recorded on 12 Aug 2026. Today's high was -4.83% below the 52-week high.
For Q1 FY27, Thyrocare Technologies Ltd reported: Revenue (Net Sales): ₹2256.60 Cr - Up 7.12% year-on-year from ₹2106.70 Cr in Q4 FY26. Net Income (PAT): ₹501.70 Cr - Up 15.12% year-on-year from ₹435.80 Cr in Q4 FY26.
